Smithfield Trust’s Novo Nordisk NVO Stock Holding History

Smithfield Trust’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3K	Hold	68	–	–	﹤0.01%	1018
2026 Q1	$2K	Sell	68 -2	-3%	-$95	﹤0.01%	1048
2025 Q4	$3K	Buy	+70	New	+$3.58K	﹤0.01%	1030
2024 Q2	–	Sell	-30	Closed	-$5K	–	1059
2024 Q1	$5K	Buy	+30	New	+$3.57K	﹤0.01%	936
2015 Q2	–	Sell	-3,840	Closed	-$102K	–	817
2015 Q1	$102K	Hold	3,840	–	–	0.02%	399
2014 Q4	$81K	Sell	3,840 -2,010	-34%	-$44.9K	0.02%	430
2014 Q3	$139K	Sell	5,850 -360	-6%	-$8.28K	0.03%	358
2014 Q2	$143K	Sell	6,210 -3,740	-38%	-$82.6K	0.03%	398
2014 Q1	$227K	Hold	9,950	–	–	0.05%	310
2013 Q4	$184K	Buy	9,950 +4,990	+101%	+$87K	0.04%	356
2013 Q3	$84K	Buy	+4,960	New	+$83.4K	0.02%	432

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Smithfield Trust's NVO Position: Q2 2026 in Review

Smithfield Trust held its Novo Nordisk (NVO) position steady in Q2 2026 at 68 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1018.

Smithfield Trust first reported a position in NVO in Q3 2013 and has held it in 11 quarters since. The position peaked at $227K in Q1 2014. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Smithfield Trust held 68 shares of Novo Nordisk worth $3K as of Q2 2026.
Smithfield Trust left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up ﹤0.01% of Smithfield Trust's portfolio in Q2 2026, its #1018 holding.
Smithfield Trust first reported a position in Novo Nordisk in Q3 2013 and has held it in 11 quarters since.
Smithfield Trust's Novo Nordisk position peaked at $227K in Q1 2014.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Smithfield Trust's 13F filing for Q2 2026, filed 5 Aug 2026.